The "NKX2-5 Gene Atrial Septal Defect with Atrioventricular Conduction Defects Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the NKX2-5 gene. This gene plays a crucial role in the development of the heart, and mutations within it can lead to congenital heart defects, such as atrial septal defects (ASDs) and atrioventricular (AV) conduction defects. ASDs are characterized by an opening in the wall between the two upper chambers of the heart, while AV conduction defects affect the electrical system that controls the heartbeat, potentially leading to arrhythmias.
The test is particularly valuable for individuals with a clinical diagnosis of these conditions or those with a family history, aiding in the accurate diagnosis and guiding appropriate management and treatment strategies. It involves the collection of a DNA sample, typically through a blood draw, which is then analyzed for specific genetic alterations in the NKX2-5 gene that are known to be associated with these cardiac anomalies.
The cost of the test at DNA Labs UAE is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it offers into the patient's condition. This testing not only facilitates early detection and intervention for affected individuals but also provides critical information for family planning and genetic counseling for families with a history of these congenital heart defects.
The CRELD1 gene plays a significant role in the development of the heart, particularly in the formation of the atrioventricular septum, which separates the heart's upper chambers (atria) from its lower chambers (ventricles). Mutations in the CRELD1 gene have been associated with atrioventricular septal defects (AVSD) and heterotaxy syndrome, a condition where the internal organs are abnormally arranged across the left-right axis of the body. These genetic anomalies can lead to complex congenital heart defects and other developmental issues.
To diagnose these genetic conditions, DNA Labs UAE offers a specialized genetic test targeting the CRELD1 gene. This test is designed to identify mutations in the CRELD1 gene that are linked to the development of partial atrioventricular septal defects and heterotaxy syndrome. The test is crucial for early diagnosis, which can aid in the management and treatment planning for affected individuals.
The cost of the CRELD1 Gene Atrioventricular Septal Defect Partial with Heterotaxy Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is performed under stringent laboratory conditions to ensure accuracy and reliability. The results from this test can provide essential genetic information for families, guiding clinical decisions and offering insights into the potential need for further medical interventions or surveillance for associated health conditions.
The HBD Gene Thalassemia Delta Genetic Test is a specialized diagnostic tool designed to identify mutations in the HBD gene, which are associated with delta-beta thalassemia, a form of thalassemia. Thalassemias are a group of inherited blood disorders characterized by reduced or absent hemoglobin production, leading to anemia and other health issues. The HBD gene plays a crucial role in hemoglobin synthesis, and mutations in this gene can disrupt normal blood cell functioning.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides critical insights for individuals suspected of having delta-beta thalassemia or carriers who may pass the condition to their offspring. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic variations indicative of the condition.
The cost of the HBD Gene Thalassemia Delta Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, encompassing the collection of the sample, the sophisticated genetic analysis, and the detailed report provided to the patient or healthcare provider. The results from this test can significantly impact patient care, guiding treatment plans, and informing family planning decisions.
The SLC19A2 gene plays a crucial role in the body's thiamine (vitamin B1) transport, and mutations in this gene can lead to Thiamine-Responsive Megaloblastic Anemia Syndrome (TRMA), also known as Rogers Syndrome. This rare, autosomal recessive disorder is characterized by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness. Early diagnosis and treatment with thiamine can significantly improve symptoms and prevent complications.
To diagnose this condition, a genetic test targeting the SLC19A2 gene can be performed. DNA Labs UAE offers this specific test, providing a comprehensive analysis to identify mutations associated with TRMA. The test cost is 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SLC19A2 gene.
This genetic test is a critical tool for confirming the diagnosis of Thiamine-Responsive Megaloblastic Anemia Syndrome, allowing for timely and appropriate management of the condition. It is particularly valuable for families with a history of TRMA, as it can aid in early detection and treatment of affected family members, significantly improving their quality of life.
The "MPL Gene Thrombocytopenia Congenital Amegakaryocytic Genetic Test" is a specialized diagnostic tool designed to identify mutations in the MPL gene, which are linked to Congenital Amegakaryocytic Thrombocytopenia (CAMT). CAMT is a rare genetic disorder characterized by a significant reduction in platelets (thrombocytopenia) due to the absence or very low levels of megakaryocytes, the cells responsible for platelet production. This condition often presents at birth or early childhood and can lead to increased risks of bleeding and other hematologic complications.
The test involves analyzing the patient's DNA to detect any abnormalities or mutations in the MPL gene, which plays a crucial role in the growth and development of megakaryocytes and platelets. Identifying these mutations is essential for confirming the diagnosis of CAMT, understanding the disease's severity, and guiding treatment decisions.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test costs 4400 AED. The laboratory utilizes cutting-edge technology and methodologies to ensure accurate and reliable results, providing essential information for the management and treatment of patients with suspected CAMT.
The ANKRD26 Gene Thrombocytopenia Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ANKRD26 gene, which are associated with Thrombocytopenia Type 2, a rare inherited blood disorder. This condition is characterized by a significantly reduced platelet count, leading to increased bleeding and bruising risks. The test is crucial for individuals with a family history of thrombocytopenia or those exhibiting symptoms, as it aids in confirming the diagnosis, understanding the risk of transmission to offspring, and facilitating personalized treatment plans. Priced at 4400 AED, the test is conducted in a state-of-the-art laboratory setting, ensuring high accuracy and reliability of results.
The "MASTL Gene Thrombocytopenia Type 2 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the MASTL gene, which are linked to Thrombocytopenia Type 2. Thrombocytopenia Type 2 is a rare genetic disorder characterized by a lower than normal platelet count, leading to increased bleeding and bruising risks. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test, which costs 4400 AED, involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic variations in the MASTL gene that may be responsible for the condition. Identifying these mutations can be crucial for the accurate diagnosis, management, and understanding of the disease's progression in affected individuals. It also provides valuable information for family planning and genetic counseling for families with a history of Thrombocytopenia Type 2. DNA Labs UAE, with its state-of-the-art facilities and expertise in genetic testing, ensures high accuracy and reliability of the test results, making it a trusted choice for patients and healthcare providers seeking genetic analysis for Thrombocytopenia Type 2.
The CYCS Gene Thrombocytopenia Type 4 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CYCS gene, which are implicated in the development of Thrombocytopenia Type 4. Thrombocytopenia Type 4, also known as autosomal dominant thrombocytopenia, is a genetic disorder characterized by a reduced platelet count, which can lead to increased bleeding and bruising. This test plays a crucial role in the accurate diagnosis and management of individuals suspected to have this condition by analyzing their genetic makeup.
Performed at the state-of-the-art facilities of DNA Labs UAE, the test ensures high accuracy and reliability. The cost of the CYCS Gene Thrombocytopenia Type 4 Genetic Test is set at 4400 AED, reflecting the intricate technology and expertise required to conduct this genetic analysis. By identifying specific mutations in the CYCS gene, healthcare providers can better understand the condition's severity, predict its progression, and tailor treatment plans to the individual needs of the patient, offering a personalized approach to managing this rare genetic disorder.
The ETV6 Gene Thrombocytopenia Type 5 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ETV6 gene that are associated with Thrombocytopenia Type 5. Thrombocytopenia Type 5, also known as ETV6-related thrombocytopenia, is a rare genetic disorder characterized by a low platelet count, which can lead to increased bleeding and bruising. The ETV6 gene plays a crucial role in the development and function of blood cells, and mutations in this gene can disrupt normal platelet production and function.
This genetic test involves collecting a DNA sample, typically through a blood draw, and analyzing the ETV6 gene for specific mutations. It is a vital tool for accurately diagnosing Thrombocytopenia Type 5, enabling healthcare providers to tailor treatment plans to the individual needs of their patients. Early and precise diagnosis can significantly improve the management of the condition and help prevent potential complications.
DNA Labs UAE offers this test at a cost of 4400 AED. The test is conducted in their state-of-the-art laboratory facilities, where they utilize advanced genetic testing technologies to ensure accurate and reliable results. Patients choosing DNA Labs UAE for the ETV6 Gene Thrombocytopenia Type 5 Genetic Test can expect professional service, confidentiality, and comprehensive support throughout the testing process.
The "GATA1 Gene Thrombocytopenia with Beta Thalassemia X-Linked Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the GATA1 gene. These mutations are known to cause a rare but significant health condition that combines thrombocytopenia (a disorder characterized by abnormally low levels of platelets in the blood) with beta thalassemia (a blood disorder that reduces the production of hemoglobin). Given its genetic basis, the condition is inherited in an X-linked manner, meaning it can be more prevalent in males who have only one X chromosome.
The test is crucial for individuals with a family history of either thrombocytopenia or beta thalassemia, presenting symptoms of these conditions, or for those seeking comprehensive genetic counseling. Early and accurate diagnosis through this test enables targeted treatment approaches, better management of symptoms, and informed family planning decisions. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to analyze the GATA1 gene accurately. Conducted at the state-of-the-art facilities of DNA Labs UAE, this test represents a critical step forward in the personalized medicine approach for managing complex genetic disorders.
